Surya Pharmaceutical Ltd

Surya Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Surya Pharmaceutical Ltd

₹ 0.16 -5.88%
14 Sep 2015
suryapharma.com
About

Surya Pharmaceuticals Ltd. ventures as a pharmaceutical company. The businesses include Contract Manufacturing, Custom Synthesis, FTE Research, and the manufacture and marketing of pharmaceuticals products and services to clients worldwide. Surya Pharmaceuticals' wide range of product portfolio includes Active Pharmaceutical Ingredients (APIs), Fine Intermediates, Finished Drug Formulations (FDFs), Phyto Pharmaceuticals and CRAMS.

[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹ 0.16
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -37.9
  • Dividend Yield 0.00 %
  • ROCE -11.8 %
  • ROE -294 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -34.2% over past five years.
  • Company has a low return on equity of -51.2% over last 3 years.
  • Company has high debtors of 1,363 days.
  • Working capital days have increased from 2,034 days to 5,556 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
-15 6 5 1 2 0 0 0
110 9 8 618 13 2 2 1
Operating Profit -125 -3 -3 -617 -11 -1 -1 -1
OPM % -54% -69% -102,843% -492% -251% -293%
-18 0 0 -219 0 0 0 0
Interest 38 62 69 16 108 0 0 0
Depreciation 34 16 16 16 16 16 16 16
Profit before tax -215 -81 -88 -868 -134 -17 -17 -17
Tax % 0% 0% 0% 0% -331% 0% 0% 0%
-215 -81 -88 -868 310 -17 -17 -17
EPS in Rs -10.60 -3.97 -4.35 -42.80 15.28 -0.83 -0.84 -0.85
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 TTM
239 283 486 723 1,134 1,600 1,623 60 3
192 231 400 602 973 1,337 1,765 214 18
Operating Profit 47 52 86 120 161 263 -142 -154 -14
OPM % 20% 18% 18% 17% 14% 16% -9% -255% -476%
0 3 5 1 13 3 -38 -35 0
Interest 14 16 26 41 62 108 179 207 108
Depreciation 6 8 9 16 21 27 35 62 63
Profit before tax 27 30 56 64 90 132 -393 -459 -185
Tax % 21% 22% 26% 12% 16% 24% -31% -34%
21 24 42 56 76 100 -273 -302 259
EPS in Rs 16.37 28.83 38.80 52.57 5.20 -13.47 -14.89 12.76
Dividend Payout % 0% 0% 3% 3% 3% 3% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -34%
3 Years: -62%
TTM: -178%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 126%
Stock Price CAGR
10 Years: -1%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: -24%
3 Years: -51%
Last Year: -294%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013
Equity Capital 11 14 14 14 14 19 20 20
Reserves 80 124 164 216 289 501 227 -75
148 196 318 501 708 1,441 1,754 2,009
54 60 124 218 375 205 126 63
Total Liabilities 293 394 621 949 1,386 2,166 2,128 2,017
62 81 162 213 229 404 728 671
CWIP 31 61 30 88 199 232 7 8
Investments 0 0 0 0 6 26 34 16
200 251 429 648 953 1,504 1,358 1,323
Total Assets 293 394 621 949 1,386 2,166 2,128 2,017

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013
24 -5 68 -8 165 69 386 166
-48 -56 -54 -121 -144 -245 -150 -8
61 25 13 103 -11 174 -241 -160
Net Cash Flow 38 -36 26 -25 10 -2 -6 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013
Debtor Days 77 95 62 69 49 66 53 1,363
Inventory Days 172 235 238 247 271 309 179 1,254
Days Payable 63 63 88 117 108 20 10 56
Cash Conversion Cycle 185 266 212 199 212 355 222 2,561
Working Capital Days 171 251 213 220 184 308 238 5,556
ROCE % 16% 20% 18% 17% 16% -11% -12%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

Credit ratings